Looks increasingly like the chinese problem will not be resolved easily as they are now talking up thromboview. Last year the strategy was to sell or divest the project now they are talking about raising funds to pursue it themselves. That will be difficult on the basis of the last set of results which involved only 42 patients and taking into account the current gfc.
Looks increasingly like the chinese problem will not be resolved...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $4.087K | 2.043M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 21195490 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 856410 | 2 |
View Market Depth
| Last trade - 14.36pm 12/11/2024 (20 minute delay) ? |
| CT1 (ASX) Chart |